Meredith Ian T
CIK 0001693920
EVP Global Chief Med Officer
Filings
8
Latest Mar 29, 2022
Issuers covered
1
Showing
8 of 8
Page 1
Track record
1 of 1 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 1 | 100% | +2.7% | +2.7% | +2.7% | +2.7% |
| 90 days | 1 | 100% | +14.6% | +14.6% | +14.6% | +14.6% |
| 180 days | 1 | 100% | +13.3% | +13.3% | +13.3% | +13.3% |
| 365 days | 1 | 0% | -9.8% | -9.8% | -9.8% | -9.8% |
Issuers
Companies where Meredith Ian T has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| BSX | Boston Scientific Corp | 8 | Mar 29, 2022 |
All filings
8 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|